RHJA
IMMU

Rice Hall James & Associates’s Immunomedics Inc IMMU Stock Holding History

Rice Hall James & Associates’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-600,319
Closed -$51M – 309
2020
Q3 		$51M Sell
600,319
-333,234
-36% -$16.9M 2.06% 10
2020
Q2 		$33.1M Sell
933,553
-127,461
-12% -$3.73M 1.42% 20
2020
Q1 		$14.3M Buy
1,061,014
+9,543
+0.9% +$161K 0.8% 39
2019
Q4 		$22.2M Buy
1,051,471
+76,614
+8% +$1.35M 0.75% 40
2019
Q3 		$12.9M Sell
974,857
-18,440
-2% -$271K 0.46% 89
2019
Q2 		$13.8M Buy
993,297
+347,781
+54% +$5.23M 0.46% 88
2019
Q1 		$12.4M Buy
+645,516
New +$10.4M 0.4% 95

Rice Hall James & Associates's IMMU Position: Q4 2020 in Review

Rice Hall James & Associates sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 600,319 shares — an estimated $51M sold.

Rice Hall James & Associates first reported a position in IMMU in Q1 2019 and held it in 7 quarters. The position peaked at $51M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Rice Hall James & Associates reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Rice Hall James & Associates sold 600,319 Immunomedics Inc shares in Q4 2020, an estimated $51M.
  • Rice Hall James & Associates first reported a position in Immunomedics Inc in Q1 2019 and held it in 7 quarters.
  • Rice Hall James & Associates's Immunomedics Inc position peaked at $51M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.